Biomarker detection is crucial for early disease diagnosis, personalized medicine strategies, and treatment monitoring. AGBL offers a comprehensive solution, including validated antibodies, essential reagents, and advanced instrumentation for diverse immunoassay techniques like ELISA, SIMOA and immunohistochemistry (IHC). This empowers researchers to identify and quantify specific protein biomarkers in biological samples, leading to earlier diagnoses and improved patient outcomes.
